Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2024-08-08 2025-12-13 234891
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2020-01-09 2020-03-05 102923
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2021-06-03 2021-10-14 140390
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2023-06-19 2025-12-02 195478
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2023-06-20 2023-07-06 195815
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2023-11-03 2024-01-19 209145
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2019-09-05 2019-12-19 93131
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2022-08-18 2023-10-06 167197
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2022-08-18 2023-07-05 167156
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2022-05-19 2022-06-09 160994
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Actual shortage 2025-08-29 2025-10-30 266199
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2025-08-29 2025-10-30 266196
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2024-03-07 2024-06-27 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Discontinued 2025-09-02 2025-09-02 266350
AERMONY RESPICLICK 113MCG POWDER (METERED DOSE) Discontinued 2025-05-28 2025-05-28 258571
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Discontinued 2024-11-05 2024-11-05 242101
ALERTEC 100MG TABLET Discontinued 2025-05-28 2025-05-28 258777
ALLERNIX 25MG TABLET Discontinued 2025-05-28 2025-05-28 258595
ALLERNIX EXTRA STRENGTH 50MG TABLET Discontinued 2025-05-28 2025-05-28 258562
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258771
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258705
BALMINIL DM (3MG/ML SUCROSE FREE) 15MG SYRUP Discontinued 2025-05-28 2025-05-28 258741
BALMINIL EXPECTORANT (SUCROSE FREE) 100MG SYRUP Discontinued 2025-05-28 2025-05-28 258750
BORTEZOMIB FOR INJECTION 3.5MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256094
CALMYLIN ACE 10MG 7.5MG 100MG SYRUP Discontinued 2024-06-28 2024-06-29 231574
CEFAZOLIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2023-11-27 2023-11-27 211558
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Discontinued 2019-08-08 2019-08-08 91175
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088